Biogen to Present at the 25th Annual Credit Suisse Healthcare Conference
Get Alerts BIIB Hot Sheet
Join SI Premium – FREE
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the 25th Annual Credit Suisse Healthcare Conference. The webcast will be live on Monday, November 7, 2016 at 9:00a.m. MT, 11:00a.m. ET. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com/investors. An archived version of the webcast will be available for 14 days following the presentation.
About BiogenThrough cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare diseases. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For more information, please visit www.biogen.com. Follow us on Twitter.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161027006225/en/
Biogen
Karen Jewell, 781-464-2442
Investor Relations
Source: Biogen Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) PT Lowered to $300 at H.C. Wainwright
- Biogen (BIIB) PT Lowered to $340 at Goldman Sachs
- Biogen (BIIB) PT Raised to $215 at Wedbush
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Credit Suisse, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!